Carderock Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-34,409
| Closed | -$2.84M | – | 65 |
|
|
2022
Q3 | $2.84M | Sell |
34,409
-20,227
| -37% | -$1.67M | 1.45% | 31 |
|
|
2022
Q2 | $5.2M | Sell |
54,636
-9,780
| -15% | -$930K | 2.17% | 14 |
|
|
2022
Q1 | $7.58M | Sell |
64,416
-1,404
| -2% | -$165K | 2.45% | 9 |
|
|
2021
Q4 | $8.53M | Buy |
65,820
+21,521
| +49% | +$2.79M | 2.05% | 20 |
|
|
2021
Q3 | $5.02M | Buy |
44,299
+1,050
| +2% | +$119K | 1.41% | 31 |
|
|
2021
Q2 | $4.48M | Sell |
43,249
-2,633
| -6% | -$273K | 1.23% | 39 |
|
|
2021
Q1 | $3.84M | Buy |
45,882
+50
| +0.1% | +$4.18K | 1.15% | 44 |
|
|
2020
Q4 | $4.18M | Buy |
45,832
+562
| +1% | +$51.3K | 1.26% | 39 |
|
|
2020
Q3 | $3.61M | Buy |
45,270
+2,179
| +5% | +$174K | 1.22% | 39 |
|
|
2020
Q2 | $2.98M | Buy |
43,091
+26,291
| +156% | +$1.82M | 1.1% | 43 |
|
|
2020
Q1 | $1.06M | Sell |
16,800
-135
| -0.8% | -$8.49K | 0.48% | 49 |
|
|
2019
Q4 | $1.32M | Buy |
+16,935
| New | +$1.32M | 0.44% | 57 |
|